Organometallic gold(I) complexes as inhibitors of thioredoxin reductase and cancer chemotherapeutics

被引：0
|
作者：
Ott, Ingo [1 ]
机构：
[1] Tech Univ Carolo Wilhelmina Braunschweig, Inst Med & Pharmaceut Chem, D-38106 Braunschweig, Germany
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2012年 / 243卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
1110-INOR
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Gold(I) Carbene Complexes Causing Thioredoxin 1 and Thioredoxin 2 Oxidation as Potential Anticancer Agents
    Schuh, Esther
    Pflueger, Carolin
    Citta, Anna
    Folda, Alessandra
    Rigobello, Maria Pia
    Bindoli, Alberto
    Casini, Angela
    Mohr, Fabian
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (11) : 5518 - 5528
  • [32] Gold(<sc>i</sc>) and gold(<sc>iii</sc>) carbene complexes from the marine betaine norzooanemonin: inhibition of thioredoxin reductase, antiproliferative and antimicrobial activity
    Mahdavi, Seyedeh Mahbobeh
    Bockfeld, Dirk
    Esarev, Igor V.
    Lippmann, Petra
    Frank, Rene
    Broenstrup, Mark
    Ott, Ingo
    Tamm, Matthias
    RSC MEDICINAL CHEMISTRY, 2024, 15 (09): : 3248 - 3255
  • [33] Gold(I) complexes of water-soluble diphos-type ligands: Synthesis, anticancer activity, apoptosis and thioredoxin reductase inhibition
    Wetzel, Corinna
    Kunz, Peter C.
    Kassack, Matthias U.
    Hamacher, Alexandra
    Boehler, Philip
    Watjen, Wim
    Ott, Ingo
    Rubbiani, Riccardo
    Spingler, Bernhard
    DALTON TRANSACTIONS, 2011, 40 (36) : 9212 - 9220
  • [34] Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system
    Wipf, P
    Lynch, SM
    Powis, G
    Birmingham, A
    Englund, EE
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2005, 3 (21) : 3880 - 3882
  • [35] Studies toward Novel Peptidomimetic Inhibitors of Thioredoxin-Thioredoxin Reductase System
    Klossowski, Szymon
    Muchowicz, Angelika
    Firczuk, Malgorzata
    Swiech, Marta
    Redzej, Adam
    Golab, Jakub
    Ostaszewski, Ryszard
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (01) : 55 - 67
  • [36] The role of thioredoxin reductase in gold nanoparticle radiosensitization effects
    Penninckx, Sebastien
    Heuskin, Anne-Catherine
    Michiels, Carine
    Lucas, Stephane
    NANOMEDICINE, 2018, 13 (22) : 2917 - 2937
  • [37] The role of thioredoxin reductase 1 in cancer
    Arner, E. S. J.
    GLOBAL ADVANCES IN SELENIUM RESEARCH FROM THEORY TO APPLICATION, 2016, : 59 - 60
  • [38] THE THIOREDOXIN-THIOREDOXIN REDUCTASE SYSTEM: OVEREXPRESSION IN THYROID CANCER
    Al-Yatama, Fatma
    Al-Bader, Maie
    Mohammed, Fawziah M. A.
    Al-Banaw, Anwar G.
    Lincoln, David T.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3192 - 3193
  • [39] Cytotoxic screening of thioredoxin reductase inhibitors as potential new anti-cancer drugs
    Santiago, Janice M.
    Espinosa, Sandraliz
    Vlaar, Cornelis P.
    Perez-Torres, Marianela
    CANCER RESEARCH, 2010, 70
  • [40] Thioredoxin Reductase Inhibition for Cancer Therapy
    Gencheva, Radosveta
    Arner, Elias S. J.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2022, 62 : 177 - 196
12345